AVEO Pharmaceuticals Langfristige Verbindlichkeiten 2011-2026 | AVEO

Langfristige Verbindlichkeiten Jährlich AVEO Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	14.7 M	14.6 M	37 M	58.8 M	18.9 M	10.9 M	9.7 M	45 M	49.4 M	36.9 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
58.8 M	9.7 M	29.6 M

Langfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name	Langfristige Verbindlichkeiten	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	101 M	$ 221.14	2.6 %	$ 5 B	Danmark
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Processa Pharmaceuticals PCSA	1.05 M	$ 2.37	1.72 %	$ 3.1 M	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 19.6	1.92 %	$ 916 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Cara Therapeutics CARA	3.35 M	-	-3.03 %	$ 260 M	USA
Phathom Pharmaceuticals PHAT	45.3 M	$ 10.35	2.88 %	$ 755 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Phio Pharmaceuticals Corp. PHIO	526 K	$ 1.27	4.09 %	$ 7.6 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.35	1.89 %	$ 344 M	Britain
Corbus Pharmaceuticals Holdings CRBP	25.1 M	$ 8.23	0.61 %	$ 110 M	USA
CRISPR Therapeutics AG CRSP	70.2 M	$ 47.4	2.09 %	$ 4.26 B	Schweiz
Cyclacel Pharmaceuticals CYCC	1.06 M	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	81.7 M	-	-	$ 3.74 B	USA
Pliant Therapeutics PLRX	866 K	$ 1.32	3.13 %	$ 81 M	USA
PMV Pharmaceuticals PMVP	169 M	$ 1.39	-0.36 %	$ 73 M	USA
Dynavax Technologies Corporation DVAX	218 M	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Enochian Biosciences ENOB	425 K	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Bellerophon Therapeutics BLPH	1.93 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Prelude Therapeutics Incorporated PRLD	32 K	$ 3.26	4.49 %	$ 251 M	USA
ProQR Therapeutics N.V. PRQR	31.9 M	$ 1.53	2.35 %	$ 99.5 M	Niderland
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.51	4.76 %	$ 864 M	Canada
Homology Medicines FIXX	45.1 M	-	0.77 %	$ 53.4 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA